Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What if summary

Swartz selling but what about the "other" 369 million shares out there?

somebody or bodies have those other shares. I think I remember the regulars that post hear accounting for like 50 million or so shares............oh and analyst on RB has like a 60 million now, or so he says.

ES would be premature in dumping All his shares on the USPTO news, unelss of course it's not good news.

Maybe some but not all at the new beginning for the MMP. IMO

GLTA



Share
New Message
Please login to post a reply